Form 4: Centene Director Acquires Shares, Updates Holdings
Insider Transaction Report
Centene Director Christopher J. Coughlin reported the acquisition of 852 shares of common stock and updated his beneficial ownership, including direct and indirect holdings.
Summary
- Christopher J. Coughlin, a Director of Centene Corp (CNC), reported changes in his beneficial ownership of the company's securities.
- On September 30, 2025, Mr. Coughlin acquired 852 shares of Centene Common Stock at a price of $0 per share.
- Following this transaction, Mr. Coughlin directly owns 12,287.926 shares of Common Stock, which includes 3,579 shares of restricted stock units subject to vesting requirements.
- Additionally, Mr. Coughlin indirectly owns 30,054 shares of Common Stock through a grantor retained annuity trust (GRAT) for the benefit of himself and his adult children, for which he serves as the sole trustee.
- Mr. Coughlin also holds 10,000 Common Stock Options (right to buy) with an exercise price of $80.57, exercisable from February 7, 2025, and expiring on February 7, 2032.
Sentiment
Score: 7
Explanation: The acquisition of shares by a director, even a relatively small amount, generally indicates positive insider sentiment and confidence in the company's future. However, it is a routine disclosure and not a major catalyst.
Positives
- A Director acquired 852 shares of common stock, indicating continued insider confidence in the company's future prospects.
- The acquisition price of $0 suggests these shares were likely part of an equity grant or vesting, representing a form of compensation and alignment of interests with shareholders.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic direction.
Industry Context
This filing is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive landscape within the healthcare services sector. It primarily reflects an individual director's equity holdings and recent acquisition.
Related Party Transactions
- Indirect ownership of 30,054 shares is held through a grantor retained annuity trust (GRAT) for the benefit of Mr. Coughlin and his adult children, with Mr. Coughlin as the sole trustee.
Stakeholder Impact
- Shareholders may view the director's acquisition of shares as a positive signal of management's confidence in the company's value and future performance.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date when Common Stock Options become exercisable. |
| 09/30/2025 | Date of the reported transaction for the acquisition of 852 common shares. |
| 10/01/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was filed. |
| 02/07/2032 | Expiration date for the Common Stock Options. |
Recommendation
holdThe filing reports a routine insider transaction where a director acquired a relatively small number of shares, which generally signals confidence but is not substantial enough to warrant a change in investment recommendation based solely on this report. It provides no new material information to alter the fundamental investment thesis for Centene Corp.
Keywords
Centene, CNC, Insider Transaction, Form 4, Beneficial Ownership, Director, Stock Acquisition, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.